ReviewNature immunology2017
'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations.
Eric Tran et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
289 papers cite itlatest 60 shown
this papertrialcites it